Jazz Pharmaceuticals, Inc. (JAZZ) Misses Q2 EPS by 9c

August 6, 2013 4:13 PM

Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) reported Q2 EPS of $1.43 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found